Journal article
The plasma peptides of breast versus ovarian cancer
Abstract
BackgroundThere is a need to demonstrate a proof of principle that proteomics has the capacity to analyze plasma from breast cancer versus other diseases and controls in a multisite clinical trial design. The peptides or proteins that show a high observation frequency, and/or precursor intensity, specific to breast cancer plasma might be discovered by comparison to other diseases and matched controls. The endogenous tryptic peptides of breast …
Authors
Dufresne J; Bowden P; Thavarajah T; Florentinus-Mefailoski A; Chen ZZ; Tucholska M; Norzin T; Ho MT; Phan M; Mohamed N
Journal
Clinical Proteomics, Vol. 16, No. 1,
Publisher
Springer Nature
Publication Date
December 2019
DOI
10.1186/s12014-019-9262-0
ISSN
1542-6416